Cargando…
Tuberculosis screening and management of latent tuberculosis infection prior to biologic treatment in patients with immune‐mediated inflammatory diseases: A longitudinal population‐based analysis using claims data
BACKGROUND AND AIM: Screening for tuberculosis before treating with biologic agents is recommended in patients with immune‐mediated inflammatory diseases (IMIDs). We conducted this study to identify adherence to the recommended practice in a real‐world setting in Japan. METHODS: We used a community‐...
Autores principales: | Iba, Arisa, Tomio, Jun, Yamana, Hayato, Sugiyama, Takehiro, Yoshiyama, Takashi, Kobayashi, Yasuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731986/ https://www.ncbi.nlm.nih.gov/pubmed/33336081 http://dx.doi.org/10.1002/hsr2.216 |
Ejemplares similares
-
Process quality of diabetes care under favorable access to healthcare: a 2-year longitudinal study using claims data in Japan
por: Tanaka, Hirokazu, et al.
Publicado: (2016) -
Prior Screening for Latent Tuberculosis Among Patients Diagnosed With Tuberculosis Disease: Missed Opportunities?
por: Fischer, Heidi, et al.
Publicado: (2023) -
1874. Prior Screening for Latent Tuberculosis among Patients Diagnosed with Active Tuberculosis: Missed Opportunities?
por: Garba, Saadiq, et al.
Publicado: (2023) -
755. Clinical Adherence to Latent Tuberculosis Screening Recommendations in Adults with Inflammatory Bowel Disease (IBD) Prior to Biologic Therapy
por: Mponponsuo, Kwadwo, et al.
Publicado: (2018) -
Screening for latent tuberculosis: the way forward for tuberculosis elimination
por: Petersen, Eskild, et al.
Publicado: (2022)